Regencell Bioscience Holdings (RGC) Current Assets (2020 - 2025)
Regencell Bioscience Holdings' (RGC) quarterly Current Assets came in at $2.4 million in Q4 2025, down 51.92% on a QoQ basis from $4.9 million in Q2 2025.
Regencell Bioscience Holdings (RGC) Current Assets (2020 - 2025) Analysis & Trends
Regencell Bioscience Holdings (RGC) has 6 years of Current Assets data on file, last reported at $2.4 million in Q4 2025.
- Quarterly Current Assets changed N/A year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 million (changed N/A YoY) and the FY2025 annual result came in at $4.9 million, up 1612.29% from the prior year.
- Current Assets retreated to $2.4 million in Q4 2025, from $4.9 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $11.6 million in Q2 2023 to a low of -$1.6 million in Q2 2022.
- A 5-year average of $2.8 million and a median of $1.0 million in 2021 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets plunged 476.07% — and 2025, when it jumped 1612.29%.
- Tracing RGC's Current Assets over 5 years: stood at -$273285.0 in 2021, then sank by 476.07% to -$1.6 million in 2022, then soared by 838.18% to $11.6 million in 2023, then slumped by 102.79% to -$324198.0 in 2024, then surged by 827.09% to $2.4 million in 2025.
- The last three Current Assets figures came in at $2.4 million (Q4 2025), $4.9 million (Q2 2025), and -$324198.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.22 Bn |
| 10 | Regencell Bioscience Holdings | 2.67 Bn | 2.67 Bn | - | 2.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.36 Mn |
| Jun 30, 2025 | 4.90 Mn |
| Jun 30, 2024 | -324,198.00 |
| Jun 30, 2023 | 11.62 Mn |
| Jun 30, 2022 | -1.57 Mn |
| Jun 30, 2021 | -273,285.00 |
| Jun 30, 2020 | 386,979.00 |